Journal of Clinical Virology

(The TQCC of Journal of Clinical Virology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19727
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past641
Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis452
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis432
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China404
Evaluation of rapid antigen test for detection of SARS-CoV-2 virus374
Comparison of seven commercial RT-PCR diagnostic kits for COVID-19357
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients282
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome279
Epidemiology and clinical features of COVID-19: A review of current literature267
COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being247
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study234
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies222
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies209
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immu194
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms185
The clinical course and its correlated immune status in COVID-19 pneumonia184
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation168
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2163
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays159
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays135
Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients132
Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study126
Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19126
Clinical characteristics and risk assessment of newborns born to mothers with COVID-19124
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu123
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic121
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review114
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG114
Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis107
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection103
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays102
Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China101
Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-1994
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories93
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?90
Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification88
Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China88
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutrali86
Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis85
Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China85
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-285
Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus84
SARS-CoV-2 detection by direct rRT-PCR without RNA extraction80
High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-280
Evaluation of the COVID19 ID NOW EUA assay78
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test76
Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria76
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests70
A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-270
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect69
Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-268
Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials68
Clinical features of pediatric patients with coronavirus disease (COVID-19)67
Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays67
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay66
Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection62
Validation of SARS-CoV-2 detection across multiple specimen types62
Challenges of Convalescent Plasma Therapy on COVID-1961
Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study61
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV61
Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection59
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis58
SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons58
Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-1956
Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-255
Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers55
Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-1954
Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-254
Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion52
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody51
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients51
Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes50
Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan49
Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits49
Pooling of SARS-CoV-2 samples to increase molecular testing throughput49
SARS-CoV-2 viral load assessment in respiratory samples48
Modeling the effects of intervention strategies on COVID-19 transmission dynamics48
Another false-positive problem for a SARS-CoV-2 antigen test in Japan46
Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital45
Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-244
Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study44
Comparison of different serological assays for SARS-CoV-2 in real life44
A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results44
SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus44
Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study44
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance43
Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection43
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort43
Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test42
Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis42
Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay40
Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus40
Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study39
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure39
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection39
SARS-CoV-2: Is it the newest spark in the TORCH?39
First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences38
Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-237
Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting37
Maternal type of CMV infection and sequelae in infants with congenital CMV: Systematic review and meta-analysis37
Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus.36
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-1936
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay36
Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR36
Development of a point-of-care test to detect SARS-CoV-2 from saliva which combines a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detect35
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)34
Single-step RT-PCR assay for dual genotyping of GI and GII norovirus strains33
Improved diagnosis of viral encephalitis in adult and pediatric hematological patients using viral metagenomics33
Human parainfluenza virus circulation, United States, 2011–201933
SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England33
Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection33
Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays33
A RT-PCR assay for the detection of coronaviruses from four genera33
Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR33
Five-minute point-of-care testing for SARS-CoV-2: Not there yet32
Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit – High mortality rate in infected patients with haematologic malignancies32
Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT31
Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: A national perspective from the pediatric Spanish Society (AEP).31
Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study31
Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures30
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.29
Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario28
Human Calicivirus Typing tool: A web-based tool for genotyping human norovirus and sapovirus sequences28
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domai28
SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility28
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples28
Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study28
Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants28
Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens28
Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge27
Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection27
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement27
Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-1927
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design27
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection27
Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness27
Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity27
Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant26
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?26
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes26
Human Bocavirus infection and respiratory tract disease identified in a UK patient cohort25
Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay25
ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease25
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommen25
Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections25
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-1925
Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection24
Dynamics of IgG-avidity and antibody levels after Covid-1923
Comparison of the GeneFinderTM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection?23
COVID-19 in Vietnam: A lesson of pre-preparation23
Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay22
Rapid screening method for the detection of SARS-CoV-2 variants of concern22
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)21
Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity21
Antiviral activity of ribavirin and favipiravir against human astroviruses21
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests21
RSV reemergence in Argentina since the SARS-CoV-2 pandemic20
Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples20
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test20
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory20
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study19
Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study19
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection19
Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-202019
Evolution of awareness and knowledge of congenital cytomegalovirus infection among health care providers in France between 2011 and 201819
Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series18
Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis18
Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients18
RT-PCR based SARS-CoV-2 variant screening assays require careful quality control17
Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response17
Redondovirus DNA in human respiratory samples17
Neutrophil-endothelial interactions in respiratory syncytial virus bronchiolitis: An understudied aspect with a potential for prediction of severity of disease17
SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.17
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis16
Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument16
Enterovirus D68 outbreak detection through a syndromic disease epidemiology network16
Unusual, neurological and severe dengue manifestations during the outbreak in Sri Lanka, 201716
The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test16
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China16
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis16
The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing16
A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay15
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain15
Epidemiological characteristics and clinical outcomes of human rhinovirus infections in a hospitalized population. Severity is independently linked to RSV coinfection and comorbidities15
Improved oral detection is a characteristic of Omicron infection and has implications for clinical sampling and tissue tropism15
Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up15
Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection15
Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory14
Insights into immune evasion of human metapneumovirus: novel 180- and 111-nucleotide duplications within viral G gene throughout 2014-2017 seasons in Barcelona, Spain14
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses14
Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay14
Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients14
Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans14
Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)14
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens14
Evaluation of sixteen ELISA SARS-CoV-2 serological tests14
Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein14
Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting14
Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants14
Molecular and clinical characterization of human adenovirus associated with acute respiratory tract infection in hospitalized children13
Human coronaviruses: Origin, host and receptor13
“The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain”13
Assessing the burden of viral co-infections in acute gastroenteritis in children: An eleven-year-long investigation13
The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong13
Comprehensive pathogen detection for ocular infections13
Increasing horizontal transmission of human T-cell leukemia virus type 1 in adolescents and young adults in Japan13
Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens13
Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline13
Correlation between monkeypox viral load and infectious virus in clinical specimens13
Evaluation of the Xpert HBV Viral Load for hepatitis B virus molecular testing13
Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples13
Droplet digital PCR quantification suggests that higher viral load correlates with improved survival in HPV-positive oropharyngeal tumours13